Molecular Partners AG (MOLN)
Molecular Partners AG Statistics
Share Statistics
Molecular Partners AG has 36.86M shares outstanding. The number of shares has increased by 12.2% in one year.
| Shares Outstanding | 36.86M |
| Shares Change (YoY) | 12.2% |
| Shares Change (QoQ) | 11.05% |
| Owned by Institutions (%) | 2.56% |
| Shares Floating | 36.76M |
| Failed to Deliver (FTD) Shares | 330 |
| FTD / Avg. Volume | 3.03% |
Short Selling Information
The latest short interest is 44.78K, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 44.78K |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 5.49 |
Valuation Ratios
The PE ratio is -1.82 and the forward PE ratio is -3.24. Molecular Partners AG's PEG ratio is 0.01.
| PE Ratio | -1.82 |
| Forward PE | -3.24 |
| PS Ratio | 16.02 |
| Forward PS | 3.7 |
| PB Ratio | 0.64 |
| P/FCF Ratio | -1.88 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Molecular Partners AG has an Enterprise Value (EV) of -68.07M.
| EV / Earnings | 1.1 |
| EV / Sales | -9.67 |
| EV / EBITDA | 1.14 |
| EV / EBIT | 1.11 |
| EV / FCF | 1.14 |
Financial Position
The company has a current ratio of 13.35, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.35 |
| Quick Ratio | 13.35 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.03 |
| Cash Flow / Debt | -16.16 |
| Interest Coverage | -1247.1 |
Financial Efficiency
Return on equity (ROE) is -0.35% and return on capital (ROIC) is -33.93%.
| Return on Equity (ROE) | -0.35% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -33.93% |
| Revenue Per Employee | 42.14K |
| Profits Per Employee | -371.16K |
| Employee Count | 167 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 21.39% in the last 52 weeks. The beta is 0.66, so Molecular Partners AG's price volatility has been higher than the market average.
| Beta | 0.66 |
| 52-Week Price Change | 21.39% |
| 50-Day Moving Average | 5.14 |
| 200-Day Moving Average | 5.56 |
| Relative Strength Index (RSI) | 50.74 |
| Average Volume (20 Days) | 10.88K |
Income Statement
In the last 12 months, Molecular Partners AG had revenue of 7.04M and earned -61.98M in profits. Earnings per share was -1.89.
| Revenue | 7.04M |
| Gross Profit | -40.81M |
| Operating Income | -61.11M |
| Net Income | -61.98M |
| EBITDA | -59.53M |
| EBIT | -61.11M |
| Earnings Per Share (EPS) | -1.89 |
Balance Sheet
The company has 67.31M in cash and 3.65M in debt, giving a net cash position of 63.66M.
| Cash & Cash Equivalents | 67.31M |
| Total Debt | 3.65M |
| Net Cash | 63.66M |
| Retained Earnings | -191.75M |
| Total Assets | 154.21M |
| Working Capital | 139.1M |
Cash Flow
In the last 12 months, operating cash flow was -59.01M and capital expenditures -808K, giving a free cash flow of -59.81M.
| Operating Cash Flow | -59.01M |
| Capital Expenditures | -808K |
| Free Cash Flow | -59.81M |
| FCF Per Share | -1.83 |
Margins
Gross margin is -579.8%, with operating and profit margins of -868.26% and -880.7%.
| Gross Margin | -579.8% |
| Operating Margin | -868.26% |
| Pretax Margin | -880.7% |
| Profit Margin | -880.7% |
| EBITDA Margin | -845.84% |
| EBIT Margin | -868.26% |
| FCF Margin | -849.86% |
Dividends & Yields
MOLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -37.43% |
| FCF Yield | -32.13% |
Analyst Forecast
Currently there are no analyst rating for MOLN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.62 |
| Piotroski F-Score | 2 |